December 2, 2022

Day

Higher Education Review magazine's cover story of December 2022 is dedicated to UniCamillus
Read More
A clinical trial on 1,700 patients in various countries: Lecanemab, an experimental drug against Alzheimer’s disease, reduces cognitive decline in 27 cases per 100.
Read More